Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.

RJ, Amato; RE, Hawkins; HL, Kaufman; JA, Thompson; P, Tomczak; C, Szczylik; M, McDonald; S, Eastty; WH, Shingler; Belin J, de; M, Goonewardena; S, Naylor; R, Harrop

doi:10.1158/1078-0432.ccr-10-2082

Public

Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study.

Shared by NobleBlocks on Sep 29, 2010 • 12:00 AM UTC

Authors:

Amato RJ

Hawkins RE

Kaufman HL

Abstract

<h4>Purpose</h4>The TroVax Renal Immunotherapy Survival Trial was a randomized, placebo-controlled phase III study that investigated whether modified vaccinia Ankara encoding the tumor antigen 5T4 (MVA-5T4) prolonged survival of patients receiving first-line standard-of-care (SOC) treatment for meta...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!